Overall Status

Unknown status (12)

Completed (8)

Not yet recruiting (5)

Recruiting (4)

Phase

phase 4 (13)

n/a (8)

phase 1 (2)

early phase 1 (1)

phase 2 (1)

phase 2/phase 3 (1)

phase 3 (1)

Collaborator

Beijing Friendship Hospital (1)

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (1)

Hebei Medical University Fourth Hospital (1)

Jiangsu HengRui Medicine Co., Ltd. (1)

Peking University Cancer Hospital & Institute (1)

inVentiv Health Clinical (1)

Intervention

peg-rhg-csf (29)

rhg-csf (8)

cytarabine (2)

etoposide (2)

g-csf (1)

mw05 (1)

neulasta (peg-rhg-csf) (1)

Study Documents

Intervention Type

drug (29)

Funder Type

Other (17)

Industry (12)

Study Type

Interventional (27)

Observational (2)

peg-rhg-csf

Showing 26 - 29 of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoma Trial (PEG-rhG-CSF)

Completed

Lymphoma

PEG-rhG-CSF

(no location specified)

Jun 16, 2016

Breast Cancer Trial (PEG-rhG-CSF, rhG-CSF)

Completed

Breast Cancer

PEG-rhG-CSF
rhG-CSF

(no location specified)

Jun 17, 2016

Breast Cancer Trial (PEG-rhG-CSF)

Completed

Breast Cancer

PEG-rhG-CSF

(no location specified)

Jun 17, 2016

Malignant Solid Tumors Trial (PEG-rhG-CSF)

Completed

Malignant Solid Tumors

PEG-rhG-CSF

(no location specified)

Jun 16, 2016